{"transactions":[{"id":711072,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-10T16:15:07.000Z","date":"2026-07-08","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier to occur of (i) July 8, 2027 or (ii) the day immediately prior to the first annual meeting of the Company's stockholders occurring after July 8, 2026."}],"balance_after":6500,"derivative":{"exercise_price":7.14,"expiration_date":"2036-07-07","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001193125-26-300918","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381994/000119312526300918/ownership.xml","form_type":"4"}},{"id":717401,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-02T22:05:59.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":7508,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in four equal quarterly installments occurring on October 1, 2026, January 1, 2027, April 1, 2027, and July 1, 2027, provided that if the issuer's 2027 annual meeting of stockholders occurs before July 1, 2027, the final quarterly vesting installment will vest on the day immediately prior to the date of such annual meeting, in each case, subject to the reporting person continuing in service on the Board as a non-employee director through the applicable vesting date."}],"balance_after":7508,"derivative":{"exercise_price":7.94,"expiration_date":"2036-07-01","underlying":"Common Stock","underlying_shares":7508},"source":{"system":"sec-edgar","filing":"0001193125-26-295059","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381994/000119312526295059/ownership.xml","form_type":"4"}},{"id":756796,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-06-01T20:08:38.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":123600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the Reporting Person's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan (the \"2021 Plan\")) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the 2021 Plan), each subject to the Reporting Person's Continuous Service through such date."}],"balance_after":123600,"derivative":{"exercise_price":0.9515,"expiration_date":"2036-05-27","underlying":"Class A Common Stock","underlying_shares":123600},"source":{"system":"sec-edgar","filing":"0001381994-26-000003","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381994/000138199426000003/ownership.xml","form_type":"4"}},{"id":766433,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true}}],"security":"Stock Option  (Right to Buy)","published_at":"2026-05-22T20:06:34.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":1441,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":1441,"derivative":{"exercise_price":298.48,"exercise_date":"2027-05-20","expiration_date":"2036-05-20","underlying":"Common Stock","underlying_shares":1441},"source":{"system":"sec-edgar","filing":"0001178670-26-000035","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000117867026000035/form4.xml","form_type":"4"}},{"id":766432,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-22T20:06:34.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":671,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by restricted stock units (RSUs) granted under the Second Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":1582,"source":{"system":"sec-edgar","filing":"0001178670-26-000035","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000117867026000035/form4.xml","form_type":"4"}},{"id":1065613,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2025-08-15T20:05:33.000Z","date":"2025-08-14","kind":"exercise","planned":true,"acquired":false,"shares":3454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F19","text":"The stock option was fully vested as of May 18, 2024."}],"balance_after":0,"derivative":{"exercise_price":189.87,"exercise_date":"2024-05-18","expiration_date":"2033-05-18","underlying":"Common Stock","underlying_shares":3454},"source":{"system":"sec-edgar","filing":"0001735276-25-000079","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000079/edgardoc.xml","form_type":"4"}},{"id":1065612,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2025-08-15T20:05:33.000Z","date":"2025-08-14","kind":"exercise","planned":true,"acquired":false,"shares":4032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F18","text":"The stock option was fully vested as of July 15, 2022."}],"balance_after":0,"derivative":{"exercise_price":171.95,"exercise_date":"2022-07-15","expiration_date":"2031-07-14","underlying":"Common Stock","underlying_shares":4032},"source":{"system":"sec-edgar","filing":"0001735276-25-000079","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000079/edgardoc.xml","form_type":"4"}},{"id":1065611,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2025-08-15T20:05:33.000Z","date":"2025-08-14","kind":"exercise","planned":true,"acquired":false,"shares":5228,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F17","text":"The stock option was fully vested as of May 16, 2025."}],"balance_after":0,"derivative":{"exercise_price":151.22,"exercise_date":"2025-05-16","expiration_date":"2034-05-16","underlying":"Common Stock","underlying_shares":5228},"source":{"system":"sec-edgar","filing":"0001735276-25-000079","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000079/edgardoc.xml","form_type":"4"}},{"id":1065610,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2025-08-15T20:05:33.000Z","date":"2025-08-14","kind":"exercise","planned":true,"acquired":false,"shares":4581,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F16","text":"The stock option was fully vested as of July 1, 2021."}],"balance_after":0,"derivative":{"exercise_price":148.77,"exercise_date":"2021-07-01","expiration_date":"2030-07-01","underlying":"Common Stock","underlying_shares":4581},"source":{"system":"sec-edgar","filing":"0001735276-25-000079","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000079/edgardoc.xml","form_type":"4"}},{"id":1065609,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2025-08-15T20:05:33.000Z","date":"2025-08-14","kind":"exercise","planned":true,"acquired":false,"shares":5153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F15","text":"The stock option was fully vested as of May 18, 2023."}],"balance_after":0,"derivative":{"exercise_price":128.31,"exercise_date":"2023-05-18","expiration_date":"2032-05-17","underlying":"Common Stock","underlying_shares":5153},"source":{"system":"sec-edgar","filing":"0001735276-25-000079","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000079/edgardoc.xml","form_type":"4"}},{"id":1065608,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2025-08-15T20:05:33.000Z","date":"2025-08-14","kind":"exercise","planned":true,"acquired":false,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"The stock option was fully vested as of July 1, 2020."}],"balance_after":0,"derivative":{"exercise_price":72.01,"exercise_date":"2020-07-01","expiration_date":"2029-06-30","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001735276-25-000079","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000079/edgardoc.xml","form_type":"4"}},{"id":1065607,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-15T20:05:33.000Z","date":"2025-08-14","kind":"sale","planned":true,"acquired":false,"shares":641,"price":442.66,"value":283745.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $442.44 to $443.10 The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":911,"source":{"system":"sec-edgar","filing":"0001735276-25-000079","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000079/edgardoc.xml","form_type":"4"}},{"id":1065606,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-15T20:05:33.000Z","date":"2025-08-14","kind":"sale","planned":true,"acquired":false,"shares":1205,"price":441.88,"value":532465.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $441.41 to $442.11 The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":1552,"source":{"system":"sec-edgar","filing":"0001735276-25-000079","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000079/edgardoc.xml","form_type":"4"}},{"id":1065605,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-15T20:05:33.000Z","date":"2025-08-14","kind":"sale","planned":true,"acquired":false,"shares":1238,"price":440.54,"value":545388.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $440.24 to $440.93 The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":2757,"source":{"system":"sec-edgar","filing":"0001735276-25-000079","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000079/edgardoc.xml","form_type":"4"}},{"id":1065604,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-15T20:05:33.000Z","date":"2025-08-14","kind":"sale","planned":true,"acquired":false,"shares":5302,"price":439.27,"value":2329009.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $438.91 to $439.89 The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":3995,"source":{"system":"sec-edgar","filing":"0001735276-25-000079","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000079/edgardoc.xml","form_type":"4"}},{"id":1065603,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-15T20:05:33.000Z","date":"2025-08-14","kind":"sale","planned":true,"acquired":false,"shares":2086,"price":438.34,"value":914377.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $437.85 to $438.71 The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":9297,"source":{"system":"sec-edgar","filing":"0001735276-25-000079","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000079/edgardoc.xml","form_type":"4"}},{"id":1065602,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-15T20:05:33.000Z","date":"2025-08-14","kind":"sale","planned":true,"acquired":false,"shares":1922,"price":437.56,"value":840990.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $436.84 to $437.83 The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":11383,"source":{"system":"sec-edgar","filing":"0001735276-25-000079","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000079/edgardoc.xml","form_type":"4"}},{"id":1065601,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-15T20:05:33.000Z","date":"2025-08-14","kind":"sale","planned":true,"acquired":false,"shares":5358,"price":436,"value":2336088.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $435.79 to $436.35 The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":13305,"source":{"system":"sec-edgar","filing":"0001735276-25-000079","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000079/edgardoc.xml","form_type":"4"}},{"id":1065600,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-15T20:05:33.000Z","date":"2025-08-14","kind":"sale","planned":true,"acquired":false,"shares":7675,"price":435.4,"value":3341695.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $434.69 to $435.66. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":18663,"source":{"system":"sec-edgar","filing":"0001735276-25-000079","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000079/edgardoc.xml","form_type":"4"}},{"id":1065599,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-15T20:05:33.000Z","date":"2025-08-14","kind":"sale","planned":true,"acquired":false,"shares":2098,"price":434.5,"value":911581.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $433.59 to $434.56. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":26338,"source":{"system":"sec-edgar","filing":"0001735276-25-000079","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000079/edgardoc.xml","form_type":"4"}},{"id":1065598,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-15T20:05:33.000Z","date":"2025-08-14","kind":"sale","planned":true,"acquired":false,"shares":1938,"price":432.94,"value":839037.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $432.10 to $433.06. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":28436,"source":{"system":"sec-edgar","filing":"0001735276-25-000079","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000079/edgardoc.xml","form_type":"4"}},{"id":1065597,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-15T20:05:33.000Z","date":"2025-08-14","kind":"sale","planned":true,"acquired":false,"shares":1985,"price":430.81,"value":855157.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $430.39 to $431.24. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":30374,"source":{"system":"sec-edgar","filing":"0001735276-25-000079","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000079/edgardoc.xml","form_type":"4"}},{"id":1065596,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-15T20:05:33.000Z","date":"2025-08-14","kind":"exercise","planned":true,"acquired":true,"shares":3454,"price":189.87,"value":655810.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 15, 2025."}],"balance_after":32359,"source":{"system":"sec-edgar","filing":"0001735276-25-000079","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000079/edgardoc.xml","form_type":"4"}},{"id":1065595,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-15T20:05:33.000Z","date":"2025-08-14","kind":"exercise","planned":true,"acquired":true,"shares":4032,"price":171.95,"value":693302.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 15, 2025."}],"balance_after":28905,"source":{"system":"sec-edgar","filing":"0001735276-25-000079","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000079/edgardoc.xml","form_type":"4"}},{"id":1065594,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-15T20:05:33.000Z","date":"2025-08-14","kind":"exercise","planned":true,"acquired":true,"shares":5228,"price":151.22,"value":790578.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 15, 2025."}],"balance_after":24873,"source":{"system":"sec-edgar","filing":"0001735276-25-000079","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000079/edgardoc.xml","form_type":"4"}},{"id":1065593,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-15T20:05:33.000Z","date":"2025-08-14","kind":"exercise","planned":true,"acquired":true,"shares":4581,"price":148.77,"value":681515.37,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 15, 2025."}],"balance_after":19645,"source":{"system":"sec-edgar","filing":"0001735276-25-000079","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000079/edgardoc.xml","form_type":"4"}},{"id":1065592,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-15T20:05:33.000Z","date":"2025-08-14","kind":"exercise","planned":true,"acquired":true,"shares":5153,"price":128.31,"value":661181.43,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 15, 2025."}],"balance_after":15064,"source":{"system":"sec-edgar","filing":"0001735276-25-000079","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000079/edgardoc.xml","form_type":"4"}},{"id":1065591,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-15T20:05:33.000Z","date":"2025-08-14","kind":"exercise","planned":true,"acquired":true,"shares":9000,"price":72.01,"value":648090.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 15, 2025."}],"balance_after":9911,"source":{"system":"sec-edgar","filing":"0001735276-25-000079","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000079/edgardoc.xml","form_type":"4"}},{"id":1094459,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-07-02T21:58:32.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":6452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in four equal quarterly installments occurring on October 1, 2025, January 1, 2026, April 1, 2026, and July 1, 2026, provided that if the issuer's 2026 annual meeting of stockholders occurs before July 1, 2026, the final quarterly vesting installment will vest on the day immediately prior to the date of such annual meeting, in each case, subject to the reporting person continuing in service on the Board as a non-employee director through the applicable vesting date."}],"balance_after":6452,"derivative":{"exercise_price":10.71,"expiration_date":"2035-07-01","underlying":"Common Stock","underlying_shares":6452},"source":{"system":"sec-edgar","filing":"0000950170-25-093311","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381994/000095017025093311/ownership.xml","form_type":"4"}},{"id":1128981,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-05-30T21:50:43.000Z","date":"2025-05-28","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the Company's 2021 Equity Incentive Plan)."}],"balance_after":50000,"derivative":{"exercise_price":0.62,"expiration_date":"2035-05-27","underlying":"Class A Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-25-015034","document":"form4-05302025_090532.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381994/000141588925015034/form4-05302025_090532.xml","form_type":"4"}},{"id":1152520,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2025-05-12T20:07:38.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":1558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":1558,"derivative":{"exercise_price":258.35,"exercise_date":"2026-05-08","expiration_date":"2035-05-08","underlying":"Common Stock","underlying_shares":1558},"source":{"system":"sec-edgar","filing":"0001735276-25-000068","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000068/edgardoc.xml","form_type":"4"}},{"id":1152519,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-12T20:07:38.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":911,"source":{"system":"sec-edgar","filing":"0001735276-25-000068","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000068/edgardoc.xml","form_type":"4"}},{"id":1173193,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-04-11T20:05:07.000Z","date":"2025-04-10","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of April 10, 2026 or the day immediately prior to the company's 2026 annual meeting of shareholders."}],"balance_after":100000,"derivative":{"exercise_price":0.58,"expiration_date":"2035-04-09","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000950170-25-053245","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381994/000095017025053245/ownership.xml","form_type":"4"}},{"id":1328239,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-17T22:00:13.000Z","date":"2024-12-16","kind":"grant","planned":false,"acquired":true,"shares":15423,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $9.44 per share. There is no change to the expiration dates or the vesting schedule of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vested as follows: 1/36th of the shares subject to the option vested monthly over three years from June 17, 2021."}],"balance_after":79317,"derivative":{"exercise_price":9.44,"expiration_date":"2031-07-28","underlying":"Class A Common Stock","underlying_shares":15423},"source":{"system":"sec-edgar","filing":"0000950170-24-137321","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1381994/000095017024137321/ownership.xml","form_type":"4"}},{"id":1328238,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-17T22:00:13.000Z","date":"2024-12-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15423,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $9.44 per share. There is no change to the expiration dates or the vesting schedule of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vested as follows: 1/36th of the shares subject to the option vested monthly over three years from June 17, 2021."}],"balance_after":0,"derivative":{"exercise_price":2.84,"expiration_date":"2031-07-28","underlying":"Class A Common Stock","underlying_shares":15423},"source":{"system":"sec-edgar","filing":"0000950170-24-137321","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1381994/000095017024137321/ownership.xml","form_type":"4"}},{"id":1328237,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-17T22:00:13.000Z","date":"2024-12-16","kind":"grant","planned":false,"acquired":true,"shares":101276,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $4.11 per share. There is no change to the expiration dates or the vesting schedule of the options."}],"balance_after":101276,"derivative":{"exercise_price":4.11,"exercise_date":"2024-05-25","expiration_date":"2033-05-24","underlying":"Class A Common Stock","underlying_shares":101276},"source":{"system":"sec-edgar","filing":"0000950170-24-137321","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1381994/000095017024137321/ownership.xml","form_type":"4"}},{"id":1328236,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-17T22:00:13.000Z","date":"2024-12-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":101276,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $4.11 per share. There is no change to the expiration dates or the vesting schedule of the options."}],"balance_after":0,"derivative":{"exercise_price":2.84,"exercise_date":"2024-05-25","expiration_date":"2033-05-24","underlying":"Class A Common Stock","underlying_shares":101276},"source":{"system":"sec-edgar","filing":"0000950170-24-137321","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381994/000095017024137321/ownership.xml","form_type":"4"}},{"id":1438007,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2024-08-08T20:10:22.000Z","date":"2024-08-06","kind":"exercise","planned":true,"acquired":false,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 3, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"This stock option was fully vested and exercisable as of June 1, 2016."}],"balance_after":0,"derivative":{"exercise_price":131.21,"exercise_date":"2016-06-01","expiration_date":"2025-06-01","underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001735276-24-000080","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000080/edgardoc.xml","form_type":"4"}},{"id":1438006,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2024-08-08T20:10:22.000Z","date":"2024-08-06","kind":"exercise","planned":true,"acquired":false,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 3, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"This stock option was fully vested and exercisable as of June 20, 2019."}],"balance_after":0,"derivative":{"exercise_price":105.26,"exercise_date":"2019-06-20","expiration_date":"2028-06-19","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001735276-24-000080","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000080/edgardoc.xml","form_type":"4"}},{"id":1438005,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-08T20:10:22.000Z","date":"2024-08-06","kind":"sale","planned":true,"acquired":false,"shares":262,"price":266.45,"value":69809.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 3, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $266.39  to $266.66. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":136,"source":{"system":"sec-edgar","filing":"0001735276-24-000080","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000080/edgardoc.xml","form_type":"4"}},{"id":1438004,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-08T20:10:22.000Z","date":"2024-08-06","kind":"sale","planned":true,"acquired":false,"shares":632,"price":264.95,"value":167448.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 3, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $264.37  to $265.09. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":398,"source":{"system":"sec-edgar","filing":"0001735276-24-000080","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000080/edgardoc.xml","form_type":"4"}},{"id":1438003,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-08T20:10:22.000Z","date":"2024-08-06","kind":"sale","planned":true,"acquired":false,"shares":3408,"price":263.72,"value":898757.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 3, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $263.29  to $264.20. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":1030,"source":{"system":"sec-edgar","filing":"0001735276-24-000080","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000080/edgardoc.xml","form_type":"4"}},{"id":1438002,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-08T20:10:22.000Z","date":"2024-08-06","kind":"sale","planned":true,"acquired":false,"shares":4367,"price":262.79,"value":1147603.93,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 3, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $262.26  to $263.26. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":4438,"source":{"system":"sec-edgar","filing":"0001735276-24-000080","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000080/edgardoc.xml","form_type":"4"}},{"id":1438001,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-08T20:10:22.000Z","date":"2024-08-06","kind":"sale","planned":true,"acquired":false,"shares":6212,"price":261.63,"value":1625245.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 3, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $261.21  to $262.21. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":8805,"source":{"system":"sec-edgar","filing":"0001735276-24-000080","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000080/edgardoc.xml","form_type":"4"}},{"id":1438000,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-08T20:10:22.000Z","date":"2024-08-06","kind":"sale","planned":true,"acquired":false,"shares":3742,"price":260.4,"value":974416.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 3, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $259.87  to $260.84. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":15017,"source":{"system":"sec-edgar","filing":"0001735276-24-000080","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000080/edgardoc.xml","form_type":"4"}},{"id":1437999,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-08T20:10:22.000Z","date":"2024-08-06","kind":"sale","planned":true,"acquired":false,"shares":1627,"price":259.56,"value":422304.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 3, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $258.85  to $259.85. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":18759,"source":{"system":"sec-edgar","filing":"0001735276-24-000080","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000080/edgardoc.xml","form_type":"4"}},{"id":1437998,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-08T20:10:22.000Z","date":"2024-08-06","kind":"exercise","planned":true,"acquired":true,"shares":9000,"price":105.26,"value":947340.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 3, 2024."}],"balance_after":20386,"source":{"system":"sec-edgar","filing":"0001735276-24-000080","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000080/edgardoc.xml","form_type":"4"}},{"id":1437997,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-08T20:10:22.000Z","date":"2024-08-06","kind":"exercise","planned":true,"acquired":true,"shares":11250,"price":131.21,"value":1476112.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 3, 2024."}],"balance_after":11386,"source":{"system":"sec-edgar","filing":"0001735276-24-000080","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000080/edgardoc.xml","form_type":"4"}},{"id":1459476,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-03T20:15:13.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":64564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in four equal quarterly installments occurring on October 1, 2024, January 1, 2025, April 1, 2025 and July 1, 2025, provided that if the Company's 2025 annual meeting of stockholders occurs before July 1, 2025, the final quarterly vesting installment will vest on the day immediately prior to the date of such annual meeting, in each case, subject to the reporting person continuing in service on the Board as a non-employee director through the applicable vesting date."}],"balance_after":64564,"derivative":{"exercise_price":0.72,"expiration_date":"2034-06-30","underlying":"Common Stock","underlying_shares":64564},"source":{"system":"sec-edgar","filing":"0000950170-24-081527","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381994/000095017024081527/ownership.xml","form_type":"4"}},{"id":1497573,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-30T20:10:06.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the Company's 2021 Equity Incentive Plan)."}],"balance_after":50000,"derivative":{"exercise_price":5,"expiration_date":"2034-05-28","underlying":"Class A Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-24-066586","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381994/000095017024066586/ownership.xml","form_type":"4"}},{"id":1509299,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2024-05-20T20:03:05.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":5228,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":5228,"derivative":{"exercise_price":151.22,"exercise_date":"2025-05-16","expiration_date":"2034-05-16","underlying":"Common Stock","underlying_shares":5228},"source":{"system":"sec-edgar","filing":"0001735276-24-000046","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000046/edgardoc.xml","form_type":"4"}},{"id":1545311,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-04-08T20:45:10.000Z","date":"2024-04-04","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of April 4, 2025 or the day immediately prior to the company's 2025 annual meeting of shareholders."}],"balance_after":60000,"derivative":{"exercise_price":0.76,"expiration_date":"2034-04-03","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000950170-24-042656","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381994/000095017024042656/ownership.xml","form_type":"4"}},{"id":1704446,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T21:05:32.000Z","date":"2023-12-16","kind":"grant","planned":false,"acquired":true,"shares":15423,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vest as follows: 1/36th of the shares subject to the option vest monthly over three years from June 17, 2021."}],"balance_after":15423,"derivative":{"exercise_price":2.84,"expiration_date":"2031-07-28","underlying":"Class A Common Stock","underlying_shares":15423},"source":{"system":"sec-edgar","filing":"0000950170-23-071471","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1381994/000095017023071471/ownership.xml","form_type":"4"}},{"id":1704445,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T21:05:32.000Z","date":"2023-12-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15423,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vest as follows: 1/36th of the shares subject to the option vest monthly over three years from June 17, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date."}],"balance_after":63894,"derivative":{"exercise_price":9.44,"expiration_date":"2031-07-28","underlying":"Class A Common Stock","underlying_shares":15423},"source":{"system":"sec-edgar","filing":"0000950170-23-071471","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1381994/000095017023071471/ownership.xml","form_type":"4"}},{"id":1704444,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T21:05:32.000Z","date":"2023-12-16","kind":"grant","planned":false,"acquired":true,"shares":101276,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in full on May 25, 2024, subject to the recipient's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Issuer's next annual stockholder meeting or a Change in Control (as defined in the 2021 Equity Incentive Plan)."}],"balance_after":101276,"derivative":{"exercise_price":2.84,"expiration_date":"2033-05-24","underlying":"Class A Common Stock","underlying_shares":101276},"source":{"system":"sec-edgar","filing":"0000950170-23-071471","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1381994/000095017023071471/ownership.xml","form_type":"4"}},{"id":1704443,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T21:05:32.000Z","date":"2023-12-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":101276,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in full on May 25, 2024, subject to the recipient's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Issuer's next annual stockholder meeting or a Change in Control (as defined in the 2021 Equity Incentive Plan)."}],"balance_after":0,"derivative":{"exercise_price":4.11,"expiration_date":"2033-05-24","underlying":"Class A Common Stock","underlying_shares":101276},"source":{"system":"sec-edgar","filing":"0000950170-23-071471","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381994/000095017023071471/ownership.xml","form_type":"4"}},{"id":1844937,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-23T21:29:14.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 22, 2024 or the day immediately prior to the company's 2024 annual meeting of shareholders."}],"balance_after":35000,"derivative":{"exercise_price":5.46,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000899243-23-016406","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381994/000089924323016406/doc4.xml","form_type":"4"}},{"id":1874341,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-31T00:04:25.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":101276,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided, that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the 2021 Equity Incentive Plan)."}],"balance_after":101276,"derivative":{"exercise_price":4.11,"expiration_date":"2033-05-24","underlying":"Class A Common Stock","underlying_shares":101276},"source":{"system":"sec-edgar","filing":"0001209191-23-033043","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381994/000120919123033043/doc4.xml","form_type":"4"}},{"id":1885132,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2023-05-19T20:04:19.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":3454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":3454,"derivative":{"exercise_price":189.87,"exercise_date":"2024-05-18","expiration_date":"2033-05-18","underlying":"Common Stock","underlying_shares":3454},"source":{"system":"sec-edgar","filing":"0001735276-23-000062","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527623000062/edgardoc.xml","form_type":"4"}},{"id":1990708,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-02-27T21:11:15.000Z","date":"2023-02-23","kind":"exercise","acquired":false,"shares":136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ALNY common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This award vested on February 23, 2023, the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This award vested on February 23, 2023, the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":136},"source":{"system":"sec-edgar","filing":"0001735276-23-000015","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527623000015/edgardoc.xml","form_type":"4"}},{"id":1990707,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-27T21:11:15.000Z","date":"2023-02-23","kind":"exercise","acquired":true,"shares":136,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":136,"source":{"system":"sec-edgar","filing":"0001735276-23-000015","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527623000015/edgardoc.xml","form_type":"4"}},{"id":2105527,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2022-11-23T21:05:26.000Z","date":"2022-11-21","kind":"exercise","acquired":false,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2022."}],"balance_after":0,"derivative":{"exercise_price":71.99,"exercise_date":"2018-06-02","expiration_date":"2027-06-01","underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001735276-22-000076","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527622000076/edgardoc.xml","form_type":"4"}},{"id":2105526,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2022-11-23T21:05:26.000Z","date":"2022-11-21","kind":"exercise","acquired":false,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2022."}],"balance_after":0,"derivative":{"exercise_price":70.2,"exercise_date":"2017-06-03","expiration_date":"2026-06-03","underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001735276-22-000076","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527622000076/edgardoc.xml","form_type":"4"}},{"id":2105525,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-23T21:05:26.000Z","date":"2022-11-21","kind":"sale","acquired":false,"shares":22500,"price":220,"value":4950000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2022."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001735276-22-000076","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527622000076/edgardoc.xml","form_type":"4"}},{"id":2105524,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-23T21:05:26.000Z","date":"2022-11-21","kind":"exercise","acquired":true,"shares":11250,"price":71.99,"value":809887.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2022."}],"balance_after":22500,"source":{"system":"sec-edgar","filing":"0001735276-22-000076","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527622000076/edgardoc.xml","form_type":"4"}},{"id":2105523,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-23T21:05:26.000Z","date":"2022-11-21","kind":"exercise","acquired":true,"shares":11250,"price":70.2,"value":789750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2022."}],"balance_after":11250,"source":{"system":"sec-edgar","filing":"0001735276-22-000076","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527622000076/edgardoc.xml","form_type":"4"}},{"id":2221834,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-24T20:31:03.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 22, 2023 or the day immediately prior to the company's 2023 annual meeting of shareholders."}],"balance_after":35000,"derivative":{"exercise_price":3.22,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000899243-22-023974","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381994/000089924322023974/doc4.xml","form_type":"4"}},{"id":2252855,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-27T12:30:47.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":41416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided, that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the 2021 Equity Incentive Plan)."}],"balance_after":41416,"derivative":{"exercise_price":10.89,"expiration_date":"2032-05-24","underlying":"Class A Common Stock","underlying_shares":41416},"source":{"system":"sec-edgar","filing":"0000899243-22-019860","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381994/000089924322019860/doc4.xml","form_type":"4"}},{"id":2262171,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2022-05-20T20:06:05.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":5153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":5153,"derivative":{"exercise_price":128.31,"exercise_date":"2023-05-18","expiration_date":"2032-05-17","underlying":"Common Stock","underlying_shares":5153},"source":{"system":"sec-edgar","filing":"0001735276-22-000050","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527622000050/edgardoc.xml","form_type":"4"}},{"id":2372510,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-02-25T21:10:01.000Z","date":"2022-02-23","kind":"grant","acquired":true,"shares":136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ALNY common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":136,"derivative":{"underlying":"Common Stock","underlying_shares":136},"source":{"system":"sec-edgar","filing":"0001735276-22-000031","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527622000031/edgardoc.xml","form_type":"4"}},{"id":2630794,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2021-07-19T20:20:52.000Z","date":"2021-07-15","kind":"grant","acquired":true,"shares":4032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":4032,"derivative":{"exercise_price":171.95,"exercise_date":"2022-07-15","expiration_date":"2031-07-14","underlying":"Common Stock","underlying_shares":4032},"source":{"system":"sec-edgar","filing":"0001735276-21-000067","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527621000067/edgardoc.xml","form_type":"4"}},{"id":2660315,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-21T20:30:39.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 16, 2022 or the day immediately prior to the company's 2022 annual meeting of shareholders."}],"balance_after":23000,"derivative":{"exercise_price":19.74,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0000899243-21-024997","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381994/000089924321024997/doc4.xml","form_type":"4"}},{"id":3089170,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2020-07-06T20:52:24.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":4581,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4581,"derivative":{"exercise_price":148.77,"exercise_date":"2021-07-01","expiration_date":"2030-07-01","underlying":"Common Stock","underlying_shares":4581},"source":{"system":"sec-edgar","filing":"0001735276-20-000080","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527620000080/edgardoc.xml","form_type":"4"}},{"id":3102858,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-22T20:15:52.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 18, 2021 or the day immediately prior to the company's 2021 annual meeting of shareholders."}],"balance_after":30000,"derivative":{"exercise_price":4.4,"expiration_date":"2030-06-17","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-20-017361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381994/000089924320017361/doc4.xml","form_type":"4"}},{"id":3471564,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2019-07-02T20:03:23.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9000,"derivative":{"exercise_price":72.01,"exercise_date":"2020-07-01","expiration_date":"2029-06-30","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001735276-19-000059","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527619000059/edgardoc.xml","form_type":"4"}},{"id":3489268,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-14T20:09:23.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 13, 2020 or the day immediately prior to the company's 2020 annual meeting of shareholders."}],"balance_after":15000,"derivative":{"exercise_price":2.83,"expiration_date":"2029-06-12","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-19-017012","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381994/000089924319017012/doc4.xml","form_type":"4"}},{"id":3882065,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-28T01:02:19.000Z","date":"2018-06-26","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 26, 2019 or the day immediately prior to the company's 2019 annual meeting of shareholders."}],"balance_after":15000,"derivative":{"exercise_price":9.09,"expiration_date":"2028-06-25","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-18-018512","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381994/000089924318018512/doc4.xml","form_type":"4"}},{"id":3885256,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2018-06-22T20:17:04.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9000,"derivative":{"exercise_price":105.26,"exercise_date":"2019-06-20","expiration_date":"2028-06-19","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001735276-18-000026","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527618000026/edgardoc.xml","form_type":"4"}},{"id":415449,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2018-04-30T17:30:15.000Z","date":"2018-04-26","kind":"grant","acquired":true,"shares":5223.881,"price":36.85,"value":192500.01485,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors."}],"balance_after":47345.774,"derivative":{"underlying":"Common Stock","underlying_shares":5223.881},"source":{"system":"sec-edgar","filing":"0001225208-18-008213","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520818008213/doc4.xml","form_type":"4"}},{"id":3996522,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2018-03-14T23:40:11.000Z","date":"2018-03-13","kind":"exercise","acquired":false,"shares":2117,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2017."}],"balance_after":0,"derivative":{"exercise_price":63.86,"exercise_date":"2014-03-31","expiration_date":"2024-01-02","underlying":"Common Stock","underlying_shares":2117},"source":{"system":"sec-edgar","filing":"0001553878-18-000022","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000155387818000022/edgardoc.xml","form_type":"4"}},{"id":3996521,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2018-03-14T23:40:11.000Z","date":"2018-03-13","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2017."}],"balance_after":0,"derivative":{"exercise_price":59.25,"exercise_date":"2015-06-05","expiration_date":"2024-06-04","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001553878-18-000022","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000155387818000022/edgardoc.xml","form_type":"4"}},{"id":3996520,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-14T23:40:11.000Z","date":"2018-03-13","kind":"sale","acquired":false,"shares":17117,"price":150,"value":2567550.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2017."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001553878-18-000022","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000155387818000022/edgardoc.xml","form_type":"4"}},{"id":3996519,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-14T23:40:11.000Z","date":"2018-03-13","kind":"exercise","acquired":true,"shares":15000,"price":59.25,"value":888750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2017."}],"balance_after":17117,"source":{"system":"sec-edgar","filing":"0001553878-18-000022","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000155387818000022/edgardoc.xml","form_type":"4"}},{"id":3996518,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-14T23:40:11.000Z","date":"2018-03-13","kind":"exercise","acquired":true,"shares":2117,"price":63.86,"value":135191.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2017."}],"balance_after":2117,"source":{"system":"sec-edgar","filing":"0001553878-18-000022","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000155387818000022/edgardoc.xml","form_type":"4"}},{"id":4172958,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2017-11-04T00:14:10.000Z","date":"2017-11-02","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option will vest as to one third of the shares on each of the first, second and third anniversaries of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":30.09,"expiration_date":"2023-06-06","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001553878-17-000057","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000155387817000057/edgardoc.xml","form_type":"4"}},{"id":4172957,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-04T00:14:10.000Z","date":"2017-11-02","kind":"sale","acquired":false,"shares":20000,"price":130,"value":2600000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2017."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001553878-17-000057","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000155387817000057/edgardoc.xml","form_type":"4"}},{"id":4172956,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-04T00:14:10.000Z","date":"2017-11-02","kind":"exercise","acquired":true,"shares":20000,"price":30.09,"value":601800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2017."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001553878-17-000057","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000155387817000057/edgardoc.xml","form_type":"4"}},{"id":4275127,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-21T21:10:39.000Z","date":"2017-06-20","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 20, 2018 or the day immediately prior to the company's 2018 annual meeting of shareholders."}],"balance_after":15000,"derivative":{"exercise_price":11.21,"expiration_date":"2027-06-19","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-17-016855","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381994/000089924317016855/doc4.xml","form_type":"4"}},{"id":4291297,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2017-06-06T20:53:33.000Z","date":"2017-06-02","kind":"grant","acquired":true,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11250,"derivative":{"exercise_price":71.99,"exercise_date":"2018-06-02","expiration_date":"2027-06-01","underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001553878-17-000018","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000155387817000018/edgardoc.xml","form_type":"4"}},{"id":427019,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2017-04-28T17:38:31.000Z","date":"2017-04-27","kind":"grant","acquired":true,"shares":5537.507,"price":33.86,"value":187499.98702,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors."}],"balance_after":42121.892,"derivative":{"underlying":"Common Stock","underlying_shares":5537.507},"source":{"system":"sec-edgar","filing":"0001225208-17-008575","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520817008575/doc4.xml","form_type":"4"}},{"id":438926,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2016-04-29T22:22:12.000Z","date":"2016-04-28","kind":"grant","acquired":true,"shares":5697.356,"price":32.91,"value":187499.98596,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors."}],"balance_after":36584.385,"derivative":{"underlying":"Common Stock","underlying_shares":5697.356},"source":{"system":"sec-edgar","filing":"0001225208-16-032024","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520816032024/doc4.xml","form_type":"4"}},{"id":451798,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2015-04-24T18:00:40.000Z","date":"2015-04-23","kind":"grant","acquired":true,"shares":4595.588,"price":35.36,"value":162499.99168,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors."}],"balance_after":30887.024,"derivative":{"underlying":"Common Stock","underlying_shares":4595.588},"source":{"system":"sec-edgar","filing":"0001225208-15-010347","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520815010347/doc4.xml","form_type":"4"}},{"id":465645,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2014-04-28T17:29:05.000Z","date":"2014-04-24","kind":"grant","acquired":true,"shares":5291.436,"price":30.71,"value":162499.99956,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors."}],"balance_after":26291.436,"derivative":{"underlying":"Common Stock","underlying_shares":5291.436},"source":{"system":"sec-edgar","filing":"0001225208-14-011189","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520814011189/doc4.xml","form_type":"4"}},{"id":517348,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2010-06-01T20:59:09.000Z","date":"2010-04-22","kind":"grant","acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On April 26, 2010, the reporting person inadvertently filed a Form 4 reporting the acquisition of 5,500 Pfizer phantom stock units that did not in fact occur.  As of April 22, 2010, the reporting person owned 21, 000 Pfizer phantom stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On April 26, 2010, the reporting person inadvertently filed a Form 4 reporting the acquisition of 5,500 Pfizer phantom stock units that did not in fact occur.  As of April 22, 2010, the reporting person owned 21, 000 Pfizer phantom stock units."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On April 26, 2010, the reporting person inadvertently filed a Form 4 reporting the acquisition of 5,500 Pfizer phantom stock units that did not in fact occur.  As of April 22, 2010, the reporting person owned 21, 000 Pfizer phantom stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On April 26, 2010, the reporting person inadvertently filed a Form 4 reporting the acquisition of 5,500 Pfizer phantom stock units that did not in fact occur.  As of April 22, 2010, the reporting person owned 21, 000 Pfizer phantom stock units."}],"balance_after":21000,"derivative":{"underlying":"Common Stock","underlying_shares":0},"source":{"system":"sec-edgar","filing":"0001225208-10-014338","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520810014338/doc4a.xml","form_type":"4/A","original_submission_date":"2010-04-26"}},{"id":519715,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2010-04-26T14:09:53.000Z","date":"2010-04-22","kind":"grant","acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors."}],"balance_after":26500,"derivative":{"underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001225208-10-010899","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520810010899/doc4.xml","form_type":"4"}},{"id":527553,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2009-10-19T20:13:03.000Z","date":"2009-10-15","kind":"grant","acquired":true,"shares":887,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received (together with $33.00 in cash for each share of Wyeth common stock) in exchange for  900 shares of Wyeth common stock in connection with the acquisition of Wyeth by Pfizer Inc. (the \"Acquisition\"). On the closing date of the Acquisition, the closing price of Wyeth's common stock was $50.39 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"I hereby disclaim beneficial ownership of all shares held by members of my family."}],"balance_after":887,"source":{"system":"sec-edgar","filing":"0000078003-09-000231","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800309000231/primary_doc.xml","form_type":"4"}},{"id":531375,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2009-04-24T21:11:37.000Z","date":"2009-04-23","kind":"grant","acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors."}],"balance_after":21000,"derivative":{"underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0000078003-09-000078","document":"aus2014.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800309000078/aus2014.xml","form_type":"4"}},{"id":550425,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2008-04-25T17:26:46.000Z","date":"2008-04-24","kind":"grant","acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These units are settled in cash following the reporting person's retirement from the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These units are settled in cash following the reporting person's retirement from the Board of Directors."}],"balance_after":15500,"derivative":{"underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0000078003-08-000073","document":"aus1725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800308000073/aus1725.xml","form_type":"4"}},{"id":582051,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2007-04-30T18:55:10.000Z","date":"2007-04-26","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These units are settled in cash following the reporting person's retirement from the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These units are settled in cash following the reporting person's retirement from the Board of Directors."}],"balance_after":10055,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000078003-07-000082","document":"aus1481.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800307000082/aus1481.xml","form_type":"4"}},{"id":591320,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16093,"kind":"person","name":"Ausiello Dennis A","position":1,"cik":"0001381994","reported_name":"Ausiello Dennis A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2006-12-04T19:52:40.000Z","date":"2006-12-01","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These units are settled in cash following the reporting person's retirement from the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These units are settled in cash following the reporting person's retirement from the Board of Directors."}],"balance_after":5000,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000078003-06-000333","document":"aus1389.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800306000333/aus1389.xml","form_type":"4"}}]}